Cargando…

Activation of Glucagon‐Like Peptide‐1 Receptor Ameliorates Cognitive Decline in Type 2 Diabetes Mellitus Through a Metabolism‐Independent Pathway

BACKGROUND: Patients with hypertension and diabetes mellitus are susceptible to dementia, but regular therapy fails to reduce the risk of dementia. Glucagon‐like peptide‐1 receptor agonists have neuroprotective effects in experimental studies. We aimed to assess the effect of liraglutide, a glucagon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qiang, Jia, Mengxiao, Yan, Zhencheng, Sun, Fang, He, Chengkang, Li, Yingsha, Zhou, Xunmei, Zhang, Hexuan, Liu, Xiaoli, Bu, Xiaona, Gao, Peng, He, Hongbo, Zhao, Zhigang, Zhu, Zhiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483500/ https://www.ncbi.nlm.nih.gov/pubmed/34250817 http://dx.doi.org/10.1161/JAHA.120.020734

Ejemplares similares

Clinical Characteristics of Target Organ Damage in Primary Aldosteronism with or without Metabolic Syndrome
por: Bu, Xiaona, et al.
Publicado: (2022)

Assessment of sublingual microcirculation for the screening of diabetic nephropathy
por: Li, Qiang, et al.
Publicado: (2022)

Detrimental Effect of C-Reactive Protein on the Cardiometabolic Cells and Its Rectifying by Metabolic Surgery in Obese Diabetic Patients
por: Sun, Fang, et al.
Publicado: (2020)

Adrenal Artery Ablation for the Treatment of Hypercortisolism Based on Adrenal Venous Sampling: A Potential Therapeutic Strategy
por: Zhou, Qing, et al.
Publicado: (2020)

Determination of adrenal hypersecretion in primary Aldosteronism without aldosterone-production adenomas
por: Sun, Fang, et al.
Publicado: (2021)

A novel use of hill function and utility of (99m)Tc-MIBI scintigraphy to detect earlier lower extremity microvascular perfusion in patients with type 2 diabetes
por: Li, Yingsha, et al.
Publicado: (2017)

Activation of Transient Receptor Potential Melastatin Subtype 8 Attenuates Cold‐Induced Hypertension Through Ameliorating Vascular Mitochondrial Dysfunction
por: Xiong, Shiqiang, et al.
Publicado: (2017)

Sodium‐Glucose Cotransporter 2 Inhibitor Canagliflozin Antagonizes Salt‐Sensitive Hypertension Through Modifying Transient Receptor Potential Channels 3 Mediated Vascular Calcium Handling
por: Zhao, Yu, et al.
Publicado: (2022)

Effects of Laparoscopic Roux-en-Y Gastric Bypass for Type 2 Diabetes Mellitus: Comparison of BMI > 30 and < 30 kg/m(2)
por: Ke, Zhigang, et al.
Publicado: (2017)

Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease
por: You, Mei, et al.
Publicado: (2022)

Low‐glucose‐sensitive TRPC6 dysfunction drives hypoglycemia‐induced cognitive impairment in diabetes
por: He, Chengkang, et al.
Publicado: (2020)

Gastrointestinal Intervention Ameliorates High Blood Pressure Through Antagonizing Overdrive of the Sympathetic Nerve in Hypertensive Patients and Rats
por: Zhang, Hexuan, et al.
Publicado: (2014)

Non-insulin determinant pathways maintain glucose homeostasis upon metabolic surgery
por: Lu, Zongshi, et al.
Publicado: (2018)

PPARδ: A Potential Therapeutic Target for the Treatment of Metabolic Hypertension
por: Jiang, Yanli, et al.
Publicado: (2019)

Transient Receptor Potential Vanilloid 1 Activation Enhances Gut Glucagon-Like Peptide-1 Secretion and Improves Glucose Homeostasis
por: Wang, Peijian, et al.
Publicado: (2012)

Short versus long biliopancreatic limb in Roux-en-Y gastric bypass surgery for treatment of type 2 diabetes mellitus
por: Ke, Zhigang, et al.
Publicado: (2020)

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus
por: Patel, Vishal J, et al.
Publicado: (2018)

Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway
por: Feng, Xiaoli, et al.
Publicado: (2011)

Activation of TRPV1 channel by dietary capsaicin improves visceral fat remodeling through connexin43-mediated Ca(2+) Influx
por: Chen, Jian, et al.
Publicado: (2015)

Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus
por: Pelle, Maria Chiara, et al.
Publicado: (2023)

Mitochondrial respiratory dysfunctions of blood mononuclear cells link with cardiac disturbance in patients with early-stage heart failure
por: Li, Peng, et al.
Publicado: (2015)

Recent Progress in the Use of Glucagon and Glucagon Receptor Antago-nists in the Treatment of Diabetes Mellitus
por: Lotfy, Mohamed, et al.
Publicado: (2014)

Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure
por: Gao, Chen, et al.
Publicado: (2019)

Butyrate ameliorates quinolinic acid–induced cognitive decline in obesity models
por: Ge, Xing, et al.
Publicado: (2023)

The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia
por: Chen, Fangzhe, et al.
Publicado: (2016)

Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia
por: Tan, Tricia M., et al.
Publicado: (2013)

Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice
por: Wei, Tianjiao, et al.
Publicado: (2023)

Glucose-independent insulin and glucagon secreted from ventral pancreas sharing a similar pattern in healthy adult rat
por: Duan, Hao, et al.
Publicado: (2022)

Increased Migration of Monocytes in Essential Hypertension Is Associated with Increased Transient Receptor Potential Channel Canonical Type 3 Channels
por: Zhao, Zhigang, et al.
Publicado: (2012)

Glucagon-like peptide-1 receptor (GLP-1R) signaling ameliorates dysfunctional immunity in COPD patients
por: Huang, Jingwen, et al.
Publicado: (2018)

Recurrent moderate hypoglycemia accelerates the progression of Alzheimer’s disease through impairment of the TRPC6/GLUT3 pathway
por: He, Chengkang, et al.
Publicado: (2022)

Increased rhythmicity in hypertensive arterial smooth muscle is linked to transient receptor potential canonical channels
por: Chen, Xiaoping, et al.
Publicado: (2010)

Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Ameliorates the Development of Periodontitis
por: Sawada, Noritaka, et al.
Publicado: (2020)

Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus
por: Onoviran, Olusola F., et al.
Publicado: (2019)

Correlation between gut microbiota and glucagon-like peptide-1 in patients with gestational diabetes mellitus
por: Liang, Yun-Yi, et al.
Publicado: (2022)

Neuroprotective Mechanisms of Glucagon-Like Peptide-1-Based Therapies in Ischemic Stroke: An Update Based on Preclinical Research
por: Yang, Xiaoyan, et al.
Publicado: (2022)

Effects of Sitagliptin on Insulin and Glucagon Levels in Type 2 Diabetes Mellitus
por: Kim, Ji Hyun
Publicado: (2015)

Glucagon-Like Peptide-1, Diabetes, and Cognitive Decline: Possible Pathophysiological Links and Therapeutic Opportunities
por: Mossello, Enrico, et al.
Publicado: (2011)

Experimental Study on the Mechanism of Cinnamaldehyde Ameliorate Proteinuria Induced by Adriamycin
por: He, Dan, et al.
Publicado: (2022)

Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
por: Hong, Yeonhee, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d6ln9ec179n6idumdsirlahet5